SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038173
Filing Date
2023-08-04
Accepted
2023-08-03 18:03:43
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-20230630.htm   iXBRL 10-Q 3843241
2 EX-10.1 rare-ex10_1.htm EX-10.1 73694
3 EX-31.1 rare-ex31_1.htm EX-31.1 19792
4 EX-32.1 rare-ex32_1.htm EX-32.1 9948
5 GRAPHIC img215928109_0.jpg GRAPHIC 164196
  Complete submission text file 0000950170-23-038173.txt   11898403

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20230630_def.xml EX-101.DEF 189390
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20230630_pre.xml EX-101.PRE 316209
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20230630.xsd EX-101.SCH 66301
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20230630_lab.xml EX-101.LAB 428576
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20230630_cal.xml EX-101.CAL 48009
68 EXTRACTED XBRL INSTANCE DOCUMENT rare-20230630_htm.xml XML 2285754
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 231141515
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences